Given the increasing evidence for the importance of gene repression by histone modifications in neuroblastoma tumorigenesis cited above, we assessed another histone methyltransferase (HMT) known to catalyse repressive epigenetic modifications in a variety of cancers, specifically protein arginine methyltransferase 5 (PRMT5). This evidence concerns the gene PRMT5 and cancer.